Search results for "Highlights"
ADA, KDIGO offer consensus statements on managing diabetes and chronic kidney disease
The American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) provided specific advice on use of metformin, sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and nonsteroidal mineralocorticoid receptor antagonists in patients with diabetes and chronic kidney disease.
https://diabetes.acponline.org/archives/2022/10/14/1.htm
14 Oct 2022
Initiation of glucose-lowering therapies may be associated with reduced physical activity
An analysis of 148 participants from three randomized trials found that starting liraglutide, empagliflozin, or sitagliptin was associated with reduction in physical activity of about 1,000 steps per day or 10 minutes of moderate to vigorous physical activity per day.
https://diabetes.acponline.org/archives/2022/09/16/2.htm
16 Sep 2022
Updated guideline on managing hyperosmolar hyperglycemic state issued by U.K. experts
The recommendations from the Joint British Diabetes Societies for Inpatient Care Group cover clinical assessment and monitoring, interventions, and assessments and prevention of harm, as well as five phases of therapy.
https://diabetes.acponline.org/archives/2022/12/09/3.htm
9 Dec 2022
Spotlight on inpatient hyperglycemia
A new guideline offered recommendations on managing hyperglycemia in hospital patients with or without diabetes. Recent studies looked at the effects of elevated blood glucose levels after surgery and in the ICU.
https://diabetes.acponline.org/archives/2022/07/08/5.htm
8 Jul 2022
Guaranteeing adequate carbs before postpartum oral glucose tolerance testing may not be necessary
An analysis of data from two prospective studies found no relationship between carbohydrate intake in the day or days before testing and glucose level 120 minutes after oral glucose tolerance testing.
https://diabetes.acponline.org/archives/2023/05/12/1.htm
12 May 2023
Disparities by race, hospital type exist in diabetes-related lower-extremity amputations
The authors of a recent study called for public awareness, screening, and accessible and early multidisciplinary care, as well as neighborhood-level public health interventions, to reduce the disproportionate burden of lower-extremity amputation in underserved communities.
https://diabetes.acponline.org/archives/2022/07/08/2.htm
8 Jul 2022
Comprehensive telehealth approach improved HbA1c in type 2 diabetes
Compared with a simpler approach of telemonitoring and care coordination, an intervention that added self-management and diet/activity support, medication management, and depression care improved outcomes in veterans with poorly controlled type 2 diabetes, a trial found.
https://diabetes.acponline.org/archives/2022/08/12/2.htm
12 Aug 2022
Manufacturer's trials find positive results for combo drug for type 2 diabetes
Tirzepatide, a not-yet-approved dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, was tested against placebo and semaglutide in recent studies.
https://diabetes.acponline.org/archives/2021/07/09/3.htm
9 Jul 2021
Cystatin C levels associated with risk of sight-threatening diabetic retinopathy
The biomarker may be useful for predicting this condition, especially in areas that don't have access to retinal imaging, according to an analysis of ophthalmology patients in the United Kingdom and India.
https://diabetes.acponline.org/archives/2022/05/13/3.htm
13 May 2022
Review finds blood pressure-lowering effects weaker in patients with type 2 diabetes
Absolute risk reductions did not differ substantially between people with and without type 2 diabetes because of the higher absolute cardiovascular risk among those with the condition, according to a new meta-analysis.
https://diabetes.acponline.org/archives/2022/08/12/1.htm
12 Aug 2022